Short Interest in BioCorRx Inc. (OTCMKTS:BICX) Grows By 222.7%

BioCorRx Inc. (OTCMKTS:BICX) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 7,100 shares, an increase of 222.7% from the February 28th total of 2,200 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 10,600 shares, the days-to-cover ratio is presently 0.7 days.

BioCorRx Stock Performance

BICX stock opened at $0.41 on Friday. The company has a market capitalization of $6.58 million, a PE ratio of -0.79 and a beta of 0.57. The company’s fifty day moving average price is $0.39 and its 200-day moving average price is $0.37. BioCorRx has a one year low of $0.26 and a one year high of $1.50.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.